AU2002328569A1 - Medicinal compositions containing angiotensin II receptor antagonist - Google Patents

Medicinal compositions containing angiotensin II receptor antagonist

Info

Publication number
AU2002328569A1
AU2002328569A1 AU2002328569A AU2002328569A AU2002328569A1 AU 2002328569 A1 AU2002328569 A1 AU 2002328569A1 AU 2002328569 A AU2002328569 A AU 2002328569A AU 2002328569 A AU2002328569 A AU 2002328569A AU 2002328569 A1 AU2002328569 A1 AU 2002328569A1
Authority
AU
Australia
Prior art keywords
compositions containing
receptor antagonist
medicinal compositions
containing angiotensin
angiotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002328569A
Other versions
AU2002328569B2 (en
AU2002328569B9 (en
Inventor
Toshimori Inaba
Toshio Sada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority claimed from PCT/JP2002/008629 external-priority patent/WO2003020315A1/en
Publication of AU2002328569A1 publication Critical patent/AU2002328569A1/en
Publication of AU2002328569B2 publication Critical patent/AU2002328569B2/en
Application granted granted Critical
Publication of AU2002328569B9 publication Critical patent/AU2002328569B9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002328569A 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin II receptor antagonist Ceased AU2002328569B9 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
JP2001-257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (en) 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin ii receptor antagonist

Publications (3)

Publication Number Publication Date
AU2002328569A1 true AU2002328569A1 (en) 2003-06-05
AU2002328569B2 AU2002328569B2 (en) 2005-09-22
AU2002328569B9 AU2002328569B9 (en) 2005-10-27

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002328569A Ceased AU2002328569B9 (en) 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin II receptor antagonist

Country Status (17)

Country Link
US (1) US20040198788A1 (en)
EP (1) EP1421953A4 (en)
KR (1) KR20040032969A (en)
CN (1) CN1589154A (en)
AU (1) AU2002328569B9 (en)
BR (1) BR0212254A (en)
CA (1) CA2459017A1 (en)
CO (1) CO5560583A2 (en)
HU (1) HUP0401696A2 (en)
IL (1) IL160438A0 (en)
MX (1) MXPA04001878A (en)
NO (1) NO20041291L (en)
NZ (1) NZ531346A (en)
PL (1) PL368843A1 (en)
RU (1) RU2004105965A (en)
WO (1) WO2003020315A1 (en)
ZA (1) ZA200401603B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3874419B2 (en) * 2003-01-31 2007-01-31 三共株式会社 Pharmaceuticals for the prevention and treatment of arteriosclerosis and hypertension
WO2007086980A2 (en) * 2005-11-10 2007-08-02 Duke University Methods of determining the risk of developing coronary artery disease
KR101345876B1 (en) * 2012-01-31 2013-12-30 인제대학교 산학협력단 Composition for preserving cells, tissue or organs containing Fimasartan
CN112979617A (en) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 Irbesartan piperazine salt and preparation method and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8705837A1 (en) * 1985-01-10 1987-05-16 Tanabe Seiyaku Co Naphthalene derivatives, process for the preparation thereof and pharmaceutical composition containing same.
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0421441B1 (en) * 1989-10-06 1995-01-25 Fujirebio Inc. Pantothenic acid derivatives
DE19675036I2 (en) * 1990-02-19 2004-10-21 Novartis Ag Acyl compounds.
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
DE69119434T2 (en) * 1990-11-26 1996-09-12 Taisho Pharmaceutical Co Ltd ANILIDE DERIVATIVE
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
IS1756B (en) * 1991-02-21 2000-12-28 Sankyo Company Limited Analogue method for the preparation of 1-biphenylmethylimidazole derivatives
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (en) * 1994-09-20 2005-11-24 京都薬品工業株式会社 Novel heterocyclic derivative, production method thereof and pharmaceutical use thereof
ATE210116T1 (en) * 1995-10-05 2001-12-15 Kyoto Pharma Ind NEW HETEROCYCLIC DERIVATIVES AND THEIR MEDICAL APPLICATIONS
FR2741619B1 (en) * 1995-11-28 1998-02-13 Pf Medicament NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (en) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd Lipid reducing
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (en) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh 1,4-Benzothiazepine-1,1-dioxide derivatives substituted with sugar residues, process for their preparation and their use
CA2445322C (en) * 2001-04-25 2011-06-14 Takeda Chemical Industries, Ltd. Use of the abc expression promoting agent pioglitazone for the treatment of arteriosclerosis obliterans

Similar Documents

Publication Publication Date Title
AU2002324624A1 (en) Sequestered antagonist formulations
IL158079A0 (en) Pharmaceutical compositions containing an interleukin-6 antagonist
AU2002313236A1 (en) Medicinal compositions
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
IL159725A0 (en) Pharmaceutical compositions containing benzimidazole derivatives
AU2002367424A1 (en) Androgen receptor antagonists
GB0111597D0 (en) Pharmaceutical compositions
AUPR833401A0 (en) G protein-coupled receptor antagonists
EG24194A (en) 5ht-a-partial agonist pharmaceutical compositions
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU2001296013A1 (en) Pgd2 receptor antagonistic pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AUPR602501A0 (en) Sustained release pharmaceutical composition
HUP0400850A3 (en) Oral pharmaceutical compositions
AU2002365655A1 (en) 5-ht7 receptor antagonists
IL160715A0 (en) Pharmaceutical compositions containing an a1 adenosine receptor antagonist
AU2002328569A1 (en) Medicinal compositions containing angiotensin II receptor antagonist
GB0104752D0 (en) Pharmaceutical compositions
EP1421953A4 (en) Medicinal compositions containing angiotensin ii receptor antagonist
GB2382302B (en) Pharmaceutical compositions
AUPR529701A0 (en) Pharmaceutical composition
AU2002346223A1 (en) Medicinal compositions
AU2002338040A1 (en) Receptor antagonist
AU2003241991A1 (en) Drug composition containing calcium channel antagonist
GB0126732D0 (en) Pharmaceutical compositions